Scarica l'app Stockscreener
0.7179
2.41%
0.0169
Precedente Chiudi:
$0.701
Aprire:
$0.7
Volume 24 ore:
215.34K
Relative Volume:
0.74
Capitalizzazione di mercato:
$90.67M
Reddito:
-
Utile/perdita netta:
$-70.78M
Rapporto P/E:
-1.282
EPS:
-0.56
Flusso di cassa netto:
$-61.27M
1 W Prestazione:
+2.56%
1M Prestazione:
-5.28%
6M Prestazione:
-51.16%
1 anno Prestazione:
-72.39%
Intervallo 1D:
$0.6901
$0.7315
Intervallo di 1 settimana:
$0.66
$0.7315
Portata 52W:
$0.66
$3.09
Nautilus Biotechnology Inc Stock (NAUT) Company Profile
Nome
Nautilus Biotechnology Inc
Settore
Industria
Telefono
206-333-2001
Indirizzo
2701 EASTLAKE AVE EAST, SEATTLE
Confronta NAUT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NAUT
Nautilus Biotechnology Inc
|
0.7179 | 88.41M | 0 | -70.78M | -61.27M | -0.56 |
|
VRTX
Vertex Pharmaceuticals Inc
|
388.94 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.38 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
443.64 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
677.32 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
308.63 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Nautilus Biotechnology Inc Stock (NAUT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-05 | Downgrade | Goldman | Neutral → Sell |
| 2024-06-27 | Iniziato | Guggenheim | Buy |
| 2024-06-03 | Ripresa | Jefferies | Hold |
| 2022-01-06 | Iniziato | Morgan Stanley | Equal-Weight |
| 2021-11-02 | Iniziato | Cowen | Outperform |
| 2021-08-04 | Iniziato | Goldman | Neutral |
| 2021-07-13 | Iniziato | Jefferies | Buy |
Mostra tutto
Nautilus Biotechnology Inc Borsa (NAUT) Ultime notizie
Combining price and volume data for Nautilus Biotechnology Inc.July 2025 PreEarnings & Weekly High Momentum Picks - Newser
Published on: 2025-08-20 02:35:17 - Newser
Order flow analysis tools used on Nautilus Biotechnology Inc.Weekly Investment Recap & High Accuracy Trade Signal Alerts - Newser
Is Nautilus Biotechnology Inc. stock poised for growth2025 Trading Recap & Daily Profit Maximizing Tips - Newser
Using R and stats models for Nautilus Biotechnology Inc. forecastingInsider Selling & Community Consensus Trade Alerts - Newser
Nautilus Biotechnology Inc. stock retracement – recovery analysisMarket Growth Summary & AI Driven Stock Movement Reports - Newser
Nautilus Biotechnology Inc. stock momentum explainedTrade Signal Summary & Daily Profit Focused Stock Screening - Newser
Why Nautilus Biotechnology Inc. stock attracts strong analyst attentionJuly 2025 Institutional & Risk Controlled Daily Plans - Newser
Detecting support and resistance levels for Nautilus Biotechnology Inc.2025 Price Targets & Weekly High Return Opportunities - Newser
Can trapped investors hope for a rebound in Nautilus Biotechnology Inc.Weekly Trade Recap & Verified Swing Trading Watchlists - Newser
Using Python tools to backtest Nautilus Biotechnology Inc. strategies2025 Stock Rankings & Daily Momentum Trading Reports - Newser
Tools to monitor Nautilus Biotechnology Inc. recovery probabilityPortfolio Gains Summary & Safe Capital Growth Trade Ideas - Newser
Can swing trading help recover from Nautilus Biotechnology Inc. lossesJuly 2025 Decliners & Reliable Volume Spike Trade Alerts - Newser
How to integrate Nautilus Biotechnology Inc. into portfolio analysis toolsGap Up & Weekly Setup with High ROI Potential - Newser
XTX Topco Ltd Invests $31,000 in Nautilus Biotechnology, Inc. (NASDAQ:NAUT) - Defense World
What makes Nautilus Biotechnology Inc. stock price move sharplyQuarterly Risk Review & Free Weekly Watchlist of Top Performers - Newser
Using data filters to optimize entry into Nautilus Biotechnology Inc.July 2025 Price Swings & Advanced Technical Analysis Signals - Newser
Building trade automation scripts for Nautilus Biotechnology Inc.2025 Valuation Update & Reliable Momentum Entry Alerts - Newser
Visual trend scoring systems applied to Nautilus Biotechnology Inc.Weekly Profit Analysis & Technical Confirmation Alerts - Newser
Quantitative breakdown of Nautilus Biotechnology Inc. recent moveWeekly Trading Summary & Community Driven Trade Alerts - Newser
Will Nautilus Biotechnology Inc. stock go up soonAnalyst Upgrade & Smart Allocation Stock Tips - Newser
Nautilus Biotechnology Inc. Consolidation Zone May Signal AccumulationJuly 2025 Levels & High Win Rate Trade Tips - beatles.ru
What Fibonacci levels say about Nautilus Biotechnology Inc. reboundWeekly Investment Recap & Advanced Technical Signal Analysis - Newser
Heatmap analysis for Nautilus Biotechnology Inc. and competitorsTrade Volume Report & Fast Momentum Stock Entry Tips - Newser
Nautilus Biotechnology Inc. At Decision Level — Rebound or ResistancePortfolio Value Summary & Daily Profit Maximizing Tips - beatles.ru
Nautilus Biotechnology Inc Azioni (NAUT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Nautilus Biotechnology Inc Azioni (NAUT) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Mallick Parag | Chief Scientist |
May 08 '25 |
Buy |
0.73 |
12,000 |
8,788 |
20,491,892 |
| Mallick Parag | Chief Scientist |
May 12 '25 |
Buy |
0.73 |
1,500 |
1,098 |
20,493,392 |
| Patel Sujal M | CEO, President, and Secretary |
Mar 19 '25 |
Buy |
0.99 |
53,300 |
53,028 |
10,117,788 |
| Patel Sujal M | CEO, President, and Secretary |
Mar 20 '25 |
Buy |
1.00 |
23,933 |
23,890 |
10,141,721 |
1.38%
0.27%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):